期刊文献+

临床试验中评价处理效应的协变量调整问题 被引量:4

Statistical adjustment of treatment effect for covariates in clinical trials
下载PDF
导出
摘要 临床试验设计和分析中常常包括影响疾病结果的非处理因素 ,这些因素被统称为协变量。对处理效应的评价 ,若不合理考虑协变量的影响 ,常常会导致结论的偏倚乃至错误。因此 ,在临床试验中要审慎地对待这一问题 ,在评价处理效应时应该考虑用协变量对其进行适当的调整 ,以达到处理效应的正确评价。试验设计阶段的协变量调整称为“事先调整” ,常用的方法有分层法、动态分配最小化法等。试验分析阶段的协变量调整称为“事后调整”,常用的方法有分层检验法、回归模型法等。通过协变量调整 ,一方面阐明病人特征在处理组间的不均衡并没有影响到处理效应的正确评价 ,提高临床试验结果的可信度 ;另外 ,协变量调整方法的合理运用还可提高统计效能。本文对处理效应评价协变量调整涉及的概念、方法、步骤等进行介绍和探讨 ,尤其强调了应用中的一些统计学事项。 Some non treatment variables that affect the outcome of a disease are often called covariates. These covariables should be considered in the design and analysis of clinical trials to obtain unbias conclusion. To ensure that any observed treatment effect is not influenced by an imbalances in baseline characteristics, both preadjustment and postadjustment are provided in the design stage and analysis stage of the trials respectively. They can improve the credibility of the trial results and increase the statistical efficiency. Based on a few papers published about adjustment for covariates and some documentations of the International Conference on Harmonization (ICH), we review the concepts, methods and procedures for adjustment of treatment effects for the influence of covariates. The statistical issues on the application of adjustment are especially discussed in great depth.
出处 《中国临床药理学与治疗学》 CAS CSCD 2002年第3期257-262,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 临床试验 处理效应 协变量 分层检验 回归模型分析 ICH clinical trial treatment effect covariate stratification minimization stratified tests regression model ICH
  • 相关文献

参考文献7

  • 1Tu D, Shalay K, Pater J. Adjustment of treatment effect for covariates in clinical trials: statistical and regulatory issues[J]. Drug Inf, 2000;34:511-23
  • 2International conference on harmonization. E9-Statistical principles for clinical trials. http://www.ifpma.org/ich1.html
  • 3International conference on harmonization. E3-Structure and content of clinical study reports. http://www.ifpma.org/ich1.html
  • 4Taves DR. Minimization: a new method of assigning patients to treatment and control group[J]. Clin Pharmacol Ther, 1974;15:443-53
  • 5Pong A, Chow SC. Statistical/practical issues in clinical trials[J]. Drug Inf, 1997;31:1167-74
  • 6Rochon J. Issues in adjusting for covariates arising postrandomization in clinical trials[J]. Drug Inf, 1999;33:1219-28
  • 7Katz MH. Multivariable analysis: a Practical guide for clinicians[J]. University of Cambridge Press, 1999:

同被引文献18

  • 1蔡宏伟,夏结来,徐德忠,高东怀,张迎.基于网络的最小化随机分组系统[J].第四军医大学学报,2004,25(14):1278-1280. 被引量:5
  • 2王陵,夏结来,李婵娟,于莉莉,王素珍.协变量的不均衡对协方差分析的影响[J].中国卫生统计,2007,24(2):158-160. 被引量:1
  • 3[1]郑筱萸.中药新药临床研究指导原则(2002年版).北京:中国医药科技出版社,2002.58.
  • 4FDA.Guideline for the Format and Content of the Clinical and Statistical Sections of an Application[M].1988:49-80.
  • 5ICH E9.Statistical Principles for Clinical Trials[M].1998:23-34.
  • 6国家食品药品监督管理局.化学药物和生物制品临床试验的生物统计学技术指导原则[M].2005:15-20.
  • 7国家食品药品监督管理局.化学药物和生物制品临床试验的生物统计学技术指导原则[S].2005.10.
  • 8国家食品药品监督管理局.药品注册管理办法.第26条.
  • 9Cai HW,Xia JL,Xu DZ,et al.A genetic minimization random allocation and bHnding system on web.Journal of Biomedical Informatics,2006,39(6):706—719.
  • 10高晨燕,冯毅,陈峰,金丕焕,苏炳华.临床试验的统计学指导原则(Ⅰ)[J].中国临床药理学杂志,1999,15(3):228-235. 被引量:13

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部